Virtual care removed the friction from getting started and, in doing so, removed the friction from disappearing. The initial visit converts well. The follow-up does not, and the follow-up is where most of the clinical value sits.
Key Takeaways
- In-person care has structural prompts for follow-up that virtual care largely lacks.
- Adherence research consistently associates continuity of clinical contact with better persistence.
- For medications with a titration phase, the first weeks are when follow-up matters most and when it is most often skipped.
- Async models make skipping easier because nothing visibly fails when you do.
- Setting your own follow-up schedule at the start is the most reliable fix.
What in-person care did that virtual care does not
Leaving an office visit involved a checkout desk, a scheduled next appointment, a card in your hand and often a reminder call. None of that was clinical care, but all of it was scaffolding that made the next visit happen.
Virtual care mostly replaced this with a portal message. A message is easy to ignore, and nothing visibly breaks when you do — the medication keeps arriving, the subscription keeps renewing, and the absence of clinical contact is invisible until something goes wrong.
| Care stage | What follow-up is for | What happens without it |
|---|---|---|
| Titration phase | Adjusting dose, managing side effects | Discontinuation from manageable side effects |
| Early response | Confirming the treatment is working | Continuing an ineffective treatment, or stopping a working one early |
| Maintenance | Monitoring, adjusting, reassessing need | Indefinite continuation without review |
| Any new symptom | Distinguishing expected from concerning | Attributing a real problem to expected side effects |
The titration window is where it matters most
For any medication with a dose-escalation schedule, the first eight to twelve weeks are the period when side effects peak, when adjustments are most useful, and when people most often stop. The adherence literature shows discontinuation heavily front-loaded into exactly this window.
A follow-up during titration is not a formality. It is the point at which slowing an escalation, adding symptomatic management, or simply confirming that what someone is experiencing is expected can be the difference between continuing and quitting.
Found Health
Weight management + coaching- Coaching bundled with the medication track
- Billed in 4-week cycles — 13 per year
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
RxSpan MD
Multi-condition portal- One login covering several treatment categories
- Reduces the number of separate portals you have to manage
- Track-specific pricing surfaces at intake
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
Feel30 TRT
Testosterone therapy- Lab work built into the intake pathway
- Ongoing monitoring cadence rather than a one-off prescription
TRT requires baseline and follow-up labs. Any provider that offers to prescribe without them is a provider to walk away from.
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
How to build your own follow-up structure
Book it at the start. Before your first dose, put a follow-up in the calendar for the point you expect to have information — typically four to six weeks in for a titrated medication.
Set a check-in trigger, not just a date. "Message the provider if X is still happening in two weeks" is more actionable than a calendar entry alone.
Write down what you would report. Weight, symptoms, side effects, adherence gaps. Ten seconds a week produces something worth reviewing; memory at week six does not.
Treat unanswered messages as data. A provider that does not respond within a reasonable window is telling you what follow-up will look like for the rest of your time with them.
Sesame Care
Pay-per-visit marketplace- You see the price before you book — no insurance claim, no surprise bill
- Brand-name FDA-approved prescriptions only on the weight-management side
- Useful for one-off visits rather than ongoing subscriptions
Zealthy
Broad telehealth- Covers several conditions beyond weight management
- Quarterly billing structure
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
Peter MD
Men's health, injectable only- Injectable GLP-1 line only
- Men's health focus across hormones and weight
Compounded medications are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness, or quality before they are marketed. Compounded GLP-1 medications are prepared by state-licensed pharmacies and are not the same as FDA-approved brand products.
What good follow-up looks like from a provider
- A scheduled check-in during titration, initiated by them rather than by you
- A response time to messages measured in hours or a day, not a week
- A clinician who can see your history rather than a generic support queue
- Willingness to adjust — slow the escalation, change the dose, address side effects
- A periodic reassessment of whether continuing is still the right call
A provider that ships medication reliably and does none of these is a fulfilment service. That may be adequate for a stable, straightforward situation, and it is worth knowing which one you have signed up for.
Frequently Asked Questions
How often should you follow up on a new medication?
For a medication with a titration schedule, contact during the first four to six weeks is where most of the value sits. After stabilization, periodic review is generally sufficient.
Is an async message a real follow-up?
It can be, if a clinician who can see your history reviews it and can act on it. A templated auto-response is not.
What if the provider does not offer follow-up?
Initiate it. Message them with specific information at a planned interval. If nothing comes back, that tells you something about whether the provider is the right one.
Does follow-up actually change outcomes?
Continuity of clinical contact is consistently associated with better persistence in the adherence literature. Persistence, in turn, is what determines whether a treatment has a chance to work.